|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1750 USD | +21.87% |
|
+25.00% | -79.41% |
| Market Cap | 3.6M 3.14M 2.9M 2.72M 5.1M 339M 5.13M 34.46M 13.36M 167M 13.5M 13.21M 580M | P/E 2026 * |
-0.12x | P/E 2027 * | -0.13x |
|---|---|---|---|---|---|
| Enterprise Value | 3.6M 3.14M 2.9M 2.72M 5.1M 339M 5.13M 34.46M 13.36M 167M 13.5M 13.21M 580M | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
53.62% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +21.87% | ||
| 1 week | +25.00% | ||
| Current month | +40.00% | ||
| 1 month | +25.00% | ||
| 3 months | +2.16% | ||
| 6 months | -78.95% | ||
| Current year | -79.41% |
| 1 week | 0.14 |  | 0.35 |
| 1 month | 0.1 | | 0.35 |
| Current year | 0.05 | | 1.2 |
| 1 year | 0.05 | | 3.09 |
| 3 years | 0.05 | | 8.48 |
| 5 years | 0.05 | | 17.4 |
| 10 years | 0.05 | | 88.92 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Cory
CEO | Chief Executive Officer | 62 | 2025-07-20 |
Kun Qian
DFI | Director of Finance/CFO | 44 | 2025-05-15 |
Chun Hua Wang
COO | Chief Operating Officer | 54 | 2016-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
David Cory
BRD | Director/Board Member | 62 | 2025-07-20 |
Zuie Chin Huang
CHM | Chairman | 61 | 2025-11-16 |
Yue Wu
BRD | Director/Board Member | 62 | 2013-03-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +21.87% | +25.00% | -87.13% | -91.78% | 3.6M | |
| -1.21% | -5.37% | +39.94% | +145.38% | 980B | |
| -2.48% | -4.17% | +51.52% | +39.07% | 550B | |
| -2.14% | -3.68% | +16.71% | +56.15% | 382B | |
| -1.75% | +0.25% | +25.86% | +16.53% | 317B | |
| +0.61% | -2.53% | +25.46% | +12.27% | 270B | |
| +0.22% | -2.67% | +24.57% | +30.34% | 269B | |
| +4.59% | +3.68% | -39.28% | -46.92% | 191B | |
| -1.19% | -4.65% | +16.56% | +47.00% | 182B | |
| -1.35% | -1.68% | +14.59% | +56.94% | 154B | |
| Average | +1.74% | -3.66% | +8.88% | +26.50% | 329.4B | |
| Weighted average by Cap. | -0.97% | -3.38% | +28.32% | +63.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -24.73M -21.56M -19.97M -18.69M -35.05M -2.33B -35.27M -237M -91.8M -1.15B -92.81M -90.82M -3.99B | -26.51M -23.11M -21.41M -20.04M -37.58M -2.5B -37.81M -254M -98.42M -1.23B -99.51M -97.38M -4.28B |
| Net Debt | - | - |
Employees
214
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-18 | 0.1750 $ | +21.87% | 25,969 |
| 26-06-17 | 0.1436 $ | -15.57% | 1,300 |
| 26-06-16 | 0.1701 $ | +15.71% | 2,077 |
| 26-06-15 | 0.1470 $ | -26.50% | 183,099 |
| 26-06-12 | 0.2000 $ | +42.86% | 35,430 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1750USD
Average target price
4.000USD
Spread / Average Target
+2,185.71%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CASI.F Stock
Select your edition
All financial news and data tailored to specific country editions
